Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy

NCT00602277 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Wild-type Reovirus

Sponsor

National Cancer Institute (NCI)